AMLODIPINE/VALSARTAN [orch, phsu]
Fixed [fndg]
Dose [qnco]
Combination [qlco]
Hypertension [dsyn]
Amlodipine [orch, phsu]
Dihydropyridine Calcium Channel Blocker [phsu]
valsartan [orch, phsu]
Angiotensin II Receptor Blocker [phsu]
Established [qlco]
Anti-Hypertensive Agents [phsu]
Fixed [fndg]
Dose [qnco]
Combinations [mnob]
AMLODIPINE/VALSARTAN [orch, phsu]
Available [ftcn]
Several [qnco]
European country [geoa]
Dose [qnco]
Titration [lbpr]
Amlodipine [orch, phsu]
valsartan [orch, phsu]
Recommended [idcn]
Changing [ftcn]
Fixed [fndg]
Dose [qnco]
Combination [qlco]
AMLODIPINE/VALSARTAN [orch, phsu]
Approved [qlco]
Dosage [qnco]
regimens [inpr]
reductions [npop]
Sitting [fndg]
Diastolic [clna]
Systolic blood pressure [clna]
Amlodipine [orch, phsu]
valsartan [orch, phsu]
placebo [topp]
randomized [resa]
DOUBLE BLIND [resa]
FACTORIAL [resa]
Trial [resa]
Patients [podg]
Mild to moderate [qlco]
Hypertension [dsyn]
Approximately [qlco]
>90 [qnco]
Patients [podg]
Receive [qlco]
Approved [qlco]
Dosages [qnco]
AMLODIPINE/VALSARTAN [orch, phsu]
Response [orga]
Defined [cnce]
Sitting diastolic blood pressure [fndg]
>90 [qnco]
mmHg [qnco]
A-10 [orch, phsu]
mmHg [qnco]
reduction [npop]
baseline [bodm]
subgroup [virs]
Trial [resa]
Antihypertensive [phsu]
Efficacy [qlco]
AMLODIPINE/VALSARTAN [orch, phsu]
Elderly [popg]
Black [popg]
Patients [podg]
Stage 2 [inpr]
Hypertension [dsyn]
Consistent [idcn]
Observed [ftcn]
Study Population [popg]
Marked [qlco]
reductions [npop]
Blood Pressure [orgf]
Observed [ftcn]
Patients [podg]
Blood Pressure [orgf]
Uncontrolled [qlco]
Various [irda]
Antihypertensives [phsu]
Switch [mnob]
Washout [tmco]
AMLODIPINE/VALSARTAN [orch, phsu]
Phase IV Study [resa]
AMLODIPINE/VALSARTAN [orch, phsu]
Well [qlco]
Clinical Trials [resa]
Peripheral edema [fndg]
Patients [podg]
Receive [qlco]
AMLODIPINE/VALSARTAN [orch, phsu]
treated [topp]
Amlodipine [orch, phsu]
